Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Axial spondyloarthritis
J Sieper, J Braun, M Dougados, D Baeten - Nature reviews Disease …, 2015 - nature.com
The term axial spondyloarthritis covers both non-radiographic disease and radiographic
disease (also known as ankylosing spondylitis). Some studies have been performed to …
disease (also known as ankylosing spondylitis). Some studies have been performed to …
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
D Van Der Heijde, J Braun, A Deodhar… - …, 2019 - academic.oup.com
In ankylosing spondylitis (AS), structural damage that occurs as a result of syndesmophyte
formation and ankylosis of the vertebral column is irreversible. Structural damage is currently …
formation and ankylosis of the vertebral column is irreversible. Structural damage is currently …
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
S Ramiro, E Nikiphorou, A Sepriano… - Annals of the …, 2023 - ard.bmj.com
Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to …
X Baraliakos, M Østergaard… - Arthritis & …, 2024 - Wiley Online Library
Objective Spinal radiographic progression is an important outcome in radiographic axial
spondyloarthritis (SpA). The objective of the phase IIIb SURPASS study was to compare …
spondyloarthritis (SpA). The objective of the phase IIIb SURPASS study was to compare …
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
Objectives To analyse the impact of tumour necrosis factor inhibitors (TNFis) on spinal
radiographic progression in ankylosing spondylitis (AS). Methods Patients with AS in the …
radiographic progression in ankylosing spondylitis (AS). Methods Patients with AS in the …
Systemic immune‐inflammation index is associated with disease activity in patients with ankylosing spondylitis
J Wu, L Yan, K Chai - Journal of clinical laboratory analysis, 2021 - Wiley Online Library
Background The systemic immune‐inflammation index (SII) is a recently developed indicator
for systemic inflammatory response. We aimed to explore the association between SII and …
for systemic inflammatory response. We aimed to explore the association between SII and …
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
Objectives To analyse the long-term relationship between disease activity and radiographic
damage in the spine in patients with ankylosing spondylitis (AS). Methods Patients from the …
damage in the spine in patients with ankylosing spondylitis (AS). Methods Patients from the …
Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database
M Arévalo, J Gratacós Masmitjà, M Moreno… - Arthritis research & …, 2018 - Springer
Abstract Objective To assess HLA-B27 influence on the clinical phenotype of Ankylosing
Spondylitis (AS) patients. Method An observational, cross-sectional and descriptive study of …
Spondylitis (AS) patients. Method An observational, cross-sectional and descriptive study of …
The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis
The term axial spondyloarthritis (axSpA) now is used frequently to describe patients with
predominantly axial symptoms who fit into the spectrum of a well-recognised rheumatic …
predominantly axial symptoms who fit into the spectrum of a well-recognised rheumatic …
Treatment strategies in axial spondyloarthritis: what, when and how?
GE Fragoulis, S Siebert - Rheumatology, 2020 - academic.oup.com
There have been major advances in the management of axial spondyloarthritis (axSpA) with
the introduction of effective biologic agents targeting TNF and IL-17A. Clinicians now have …
the introduction of effective biologic agents targeting TNF and IL-17A. Clinicians now have …